This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Ranked Income Stocks to Buy for January 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 28th
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $38.95, moving +0.96% from the previous trading session.
Equity Residential (EQR) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Equity Residential's (EQR) Q4 performance is likely to reflect benefits from strong rental housing demand, which is expected to have supported rental rate and occupancy level despite high supply.
Is Omega Healthcare Investors (OHI) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (OHI) Outperforming Other Finance Stocks This Year?
Boston Properties (BXP) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Encouraging job reports and economic improvement likely to have supported Boston Properties' (BXP) Q4 and 2018 performance. Active leasing and base rent growth remain driving factors.
Key Factors to Drive SL Green's (SLG) Earnings This Season
by Zacks Equity Research
SL Green Realty's (SLG) office portfolio will likely gain from economic improvement and job expansion. These tailwinds are anticipated to have supported rental revenue growth in the fourth quarter.
Third Straight Week of Gains to Start 2019
by David Borun
Positive sentiment erases 2018's losses.
Key Factors to Impact Prologis' (PLD) Earnings This Season
by Zacks Equity Research
Prologis' (PLD) Q4 results likely to reflect healthy fundamentals of the industrial real estate market, backed by an improving economy and strengthening e-commerce market.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $38.23 in the latest trading session, marking a +0.5% move from the prior day.
Top Ranked Income Stocks to Buy for January 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 15th
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $36.83, marking a +0.99% move from the previous day.
Has Omega Healthcare Investors (OHI) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Is (OHI) Outperforming Other Finance Stocks This Year?
5 REITs to Scoop Gains After a Stellar U.S. Jobs Report
by Moumita Chattopadhyay
With economic indicators holding strong and market dynamics of individual asset categories playing a pivotal role in determining REITs' operating performance, there are adequate scopes to excel.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $35.02 in the latest trading session, marking a +1.42% move from the prior day.
Omega Healthcare to Buy MedEquities Realty in $600M Deal
by Zacks Equity Research
Omega Healthcare (OHI) will likely ride on growth curve, given its focus on accretive buyouts this year, after closing the sale of most of its assets and repositioning itself in 2018.
Company News For Jan 3, 2019
by Zacks Equity Research
Companies in the news are: GOOGL, TSLA, PRQR, OHI and MRT
5 High Yield Dividend Stocks That Gained More Than 30% in 2018
by Zacks Equity Research
These high dividend yield stocks have gained significantly this year and are likely to enhance portfolio returns.
Omega (OHI) in Focus: Stock Moves 5.5% Higher
by Zacks Equity Research
Omega (OHI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Omega Healthcare Investors (OHI) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 1.32% and 0.49%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Host Hotels (HST) Beats on Q3 FFO & Revenues, Revises Outlook
by Zacks Equity Research
Host Hotels & Resorts' (HST) Q3 results reflect improvements in food and beverage sales, operations of Hyatt portfolio acquired and productivity gains, partly muted by impact of dispositions.
Omega Healthcare (OHI) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Omega Healthcare (OHI) will likely experience higher rental income in third-quarter 2018. Also, we expect operator-transition efforts to support its performance.
Why Omega (OHI) Might Surprise This Earnings Season
by Zacks Equity Research
Omega (OHI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for W. P. Carey (WPC) This Earnings Season?
by Zacks Equity Research
W. P. Carey's (WPC) Q3 results likely to benefit from the company's high-quality portfolio and strategic investments.
Macerich (MAC) Q3 FFO Misses Estimates, Revenues Beat
by Zacks Equity Research
Macerich's (MAC) Q3 results highlight occupancy uptick, higher tenant sales, as well as improving same-center earnings.
Federal Realty (FRT) Q3 FFO & Revenues Top Estimates, View Up
by Zacks Equity Research
Federal Realty Investment Trust's (FRT) Q3 results highlight solid leasing activity and continued growth in property operating income.